Quick contact info

We are a branded IPR-based pharmaceutical Company focusing on frontier markets, with a vast and growing portfolio of drugs across multiple therapeutic segments.

icon_widget_image Monday to Friday 8.30AM to 5PM, Saturday & Sunday - CLOSED icon_widget_image BALAXI HEALTHCARE GUATEMALA,S.A Address :- 23 Avenida Interconexion naranjo-Minervas, 12-90, Lote 2, Sector 2 A Zona 4 de Mixco, Complejo zona Empresarial El naranjo, Condominio Industrial las Tunas 3, Cuidad de Guatemala, Guatemala icon_widget_image 2316-3216 icon_widget_image Pharma.guatemala@balaxi.com
Read MoreRead More

BRANDED PRODUCTS

BRANDED PRODUCTS

Read More

BRANDED PRODUCTS

Read More

BRANDED PRODUCTS

Read More

Operations

Operations
Commencement

2014

Number of Warehouses

2

Vehicles in Delivery fleet

3

Share of Branded Generics

14%

About the Company

Balaxi Pharma
An Overview

We are a branded IPR-based pharmaceutical Company focusing on frontier markets, with a vast and growing portfolio of drugs across multiple therapeutic segments.Our value system is the foundation for transparency and strong corporate governance.

Explore our Portfolio

Our Business

Balaxi Health Dominicana first started operations in September 2016. With a portfolio of 135 generic and branded generics across 35 therapeutic segments in 9 finished dosage forms, it has grown to be one of the top three pharmaceutical importers. We have a 10,000 sq ft central distribution warehouse along with our own fleet of delivery vehicles. We have multiple salesmen and promoters covering the entire country.

What Drives Us?

Principles

Mission

Our mission is to establish strong portfolios of pharmaceutical formulations registrations and strong channel networks in each market we target. The Company also aims to establish its presence and expand into 20 frontier markets over the next 5 years.

Vision

Our vision is to be amongst top pharmaceutical players in multiple global frontier markets, giving us scale, market homogeneity, healthy margins, and quality growth where value and volume are both established in a balanced way.

Our Brands

Our Brands
136 136

Products

Products

35 35

Therapeutic

Segments

9 9

Dosage

Forms

2 2

Number of

Warehouses

Leadership Team

Leadership

Principle of Operations

Principles

Intellectual Property Research

Undertake proprietary market research and assess the demand for various products best suited to each local market.

Product Registrations

The Company currently has 548 pharmaceutical product registrations as on date.

Asset-Light Production

Use capital efficiently to optimise the speed-to market for introducing products into new markets, while maintaining a healthy ROA.

Infrastructure and Distribution Strength

The company-owned wide distribution network is an enabler to penetrate the market efficiently and successfully through a “stock & sell” model.

IPR Management

IPR Management

Business Strategy

At Balaxi, our business strategies are responsible for creating a portfolio of valuable pharmaceutical products and taking them to diverse geographies across the world

Market research

We undertake proprietary market research and assess the demand for various products in our target markets.

Product Registrations

As of today, we have 548 valid pharmaceutical product registrations across different countries in the world.

Responsibility in Practice

Responsibility